Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma
- DOI
- 10.2967/jnumed.126.272770
- Published
- 2026-09-10
- Container
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.126.272770,
title = {Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma},
author = {Salvatore M. Aspromonte and Tamar Y. Feinberg and Somali Gavane and Candace Parker and Ali Cihan and Daoqi You and Salomon A. Tendler and Jaime Alvarez-Perez and Samantha Brosius and Armaan Siddiquee and Dylan Domenico and Glorymar Ibañez and Emily Stockfisch and James M. Bean and Anne M. Cochrane and Umesh Bhanot and Satish K. Tickoo and Achim Jungbluth and Denise Frosina and Paola Angelini and Neerav Shukla and Serge K. Lyashchenko and John T. Poirier and Heiko Schoder and Charles M. Rudin and Jason S. Lewis and Kevin J. Curran and Anthony Daniyan and Mark P. Dunphy and Julia L. Glade Bender and Shakeel Modak and Filemon S. Dela Cruz and Andrew L. Kung},
year = {2026},
journal = {Journal of Nuclear Medicine},
doi = {10.2967/jnumed.126.272770},
url = {https://doi.org/10.2967/jnumed.126.272770}
}RIS
TY - JOUR TI - Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma AU - Salvatore M. Aspromonte AU - Tamar Y. Feinberg AU - Somali Gavane AU - Candace Parker AU - Ali Cihan AU - Daoqi You AU - Salomon A. Tendler AU - Jaime Alvarez-Perez AU - Samantha Brosius AU - Armaan Siddiquee AU - Dylan Domenico AU - Glorymar Ibañez AU - Emily Stockfisch AU - James M. Bean AU - Anne M. Cochrane AU - Umesh Bhanot AU - Satish K. Tickoo AU - Achim Jungbluth AU - Denise Frosina AU - Paola Angelini AU - Neerav Shukla AU - Serge K. Lyashchenko AU - John T. Poirier AU - Heiko Schoder AU - Charles M. Rudin AU - Jason S. Lewis AU - Kevin J. Curran AU - Anthony Daniyan AU - Mark P. Dunphy AU - Julia L. Glade Bender AU - Shakeel Modak AU - Filemon S. Dela Cruz AU - Andrew L. Kung PY - 2026 JO - Journal of Nuclear Medicine DO - 10.2967/jnumed.126.272770 UR - https://doi.org/10.2967/jnumed.126.272770 ER -
APA
Aspromonte, S. M., Feinberg, T. Y., Gavane, S., Parker, C., Cihan, A., You, D., Tendler, S. A., Alvarez-Perez, J., Brosius, S., Siddiquee, A., Domenico, D., Ibañez, G., Stockfisch, E., Bean, J. M., Cochrane, A. M., Bhanot, U., Tickoo, S. K., Jungbluth, A., Frosina, D., Angelini, P., Shukla, N., Lyashchenko, S. K., Poirier, J. T., Schoder, H., Rudin, C. M., Lewis, J. S., Curran, K. J., Daniyan, A., Dunphy, M. P., Bender, J. L. G., Modak, S., Cruz, F. S. D., & Kung, A. L. (2026). Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272770
Source records
- crossref · retrieved 2026-09-25T07:25:47.491Z